Heres what you need to know about the Paxlovid antiviral drug, monoclonal antibodies and other COVID-19 treatment options.
In late April, the White House announced that it was increasing access to Paxlovid, an antiviral pill manufactured by Pfizer, as well as other COVID-19 treatments.
As more contagious COVID-19 variants emerge and cases are on the rise in parts of the United States, interest is spiking in Paxlovid, monoclonal antibodies and other treatments.
The conversation on social media has turned specifically to Paxlovid. Some people have said the drug is reserved for high-risk patients, while others are discussing reported cases of relapse in COVID-19 symptoms after a course of the drug.
VERIFY explains the facts about Paxlovid and other COVID-19 treatments.
THE SOURCES
FAST FACTS
Paxlovid authorized for high-risk patients:Paxlovid, an antiviral pill manufactured by Pfizer, is authorized for emergency use by the FDA for treatment of mild to moderate coronavirus disease in adults and patients 12 and older who are at high risk for severe COVID-19. This includes people with common conditions like asthma, diabetes, high blood pressure and depression, among others.
Potential COVID-19 relapse after Paxlovid: Federal health agencies are investigating reports of relapse in COVID-19 symptoms after a course of Paxlovid. Its unclear right now what might be causing this, but health experts still say the pill is effective at reducing COVID-19 symptoms and rates of hospitalization.
Second antiviral pill: Molnupiravir, manufactured by Merck, is the second antiviral pill authorized for emergency use to treat COVID and its available to people ages 18 and older who are at high risk for severe COVID-19.
Monoclonal antibody treatment:Some people with mild to moderate COVID-19 illness may also qualify for treatment with monoclonal antibodies, which are given intravenously soon after a person develops symptoms.
PAXLOVID
In December 2021, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Pfizers Paxlovid, the first antiviral drug to treat COVID-19. Its available by prescription only and should be started as soon as possible after a COVID-19 diagnosis and within five days of symptoms.
The entire idea is to catch it [COVID] when it's early. It can kind of start off as a sniffle ora body ache, and then progress. And its usually that week later where people get extremely sick and hospitalized, said Shira Abeles, M.D., an infectious disease specialist at the University of California San Diego.
The drug is given as three tablets taken together twice daily for five days, for a total of 30 tablets. It is not authorized for use for longer than five days in a row, according to the FDA.
When applying for FDA authorization, Pfizer presented clinical trial data collected before omicron took hold in the U.S. that showed unvaccinated people who took the drug were 89% less likely to be hospitalized or die from COVID-19 compared to people in the placebo group.
A study published by the New England Journal of Medicine in March 2022 also found that the ingredients in Paxlovid are similarly effective against the omicron variant compared to other variants of concern.
If youre prescribed Paxlovid, two of the pills in your three-pill dose will be nirmatrelvir, which inhibits the SARS-CoV-2 protein from replicating, infectious disease experts at Yale Medicine explain. The other pill is ritonavir, a drug that was once used to treat HIV/AIDS, but is now used to boost levels of antiviral medications.
As a COVID-19 treatment, ritonavir essentially shuts down nirmatrelvirs metabolism in the liver, so that it doesnt move out of your body as quickly, which means it can work longer giving it a boost to help fight the infection, according to Yale Medicine experts.
Paxlovid is authorized for the treatment of mild to moderate coronavirus disease in adults and patients ages 12 and older who are at high risk for progression to severe COVID-19, including hospitalization and death, the FDA said.
But the risk factors that qualify someone to receive Paxlovid include some common medical conditions, in addition to more serious or rare ones.
The Centers for Disease Control and Prevention (CDC) lists medical conditions on its websitethat make a person more likely to get very sick with COVID-19, including cancer, chronic kidney or liver disease, and heart conditions. Other more common medical conditions like moderate to severe asthma, diabetes and high blood pressure, mood disorders like depression, and being overweight or obese also make someone more likely to get very sick with the virus.
The full list is available online but may not include all conditions that put someone at higher risk of severe coronavirus illness.
Adults ages 50 and older are also more likely to be hospitalized or die from COVID-19, especially if they are unvaccinated, according to the CDC.
The FDA says health care providers should consider the benefit-risk for an individual patient when prescribing Paxlovid.
Paxlovid has not been used to treat pregnant or breastfeeding people, but the benefit of taking the drug may be greater than the risk from treatment for a mother and unborn baby, according to the FDA.
Does Paxlovid have side effects?
Common side effects of Paxlovid include an altered sense of taste, diarrhea, high blood pressure or muscle aches.
Are people relapsing after taking Paxlovid?
In a blog post for the New England Journal of Medicines Journal Watch, contributing editor Paul Sax, M.D., documented a case where his patient with HIV relapsed, meaning her COVID-19 symptoms returned, after taking Paxlovid. The patient had more nasal congestion, cough and fatigue not as bad as when the illness started, but unmistakably a relapse, Sax wrote.
The patients at-home COVID-19 test was also positive again after her symptoms returned, meaning its safe to assume she was still contagious, Sax added.
The National Institutes of Allergy and Infectious Diseases (NIAID) confirmed there are anecdotal reports of cases where the amount of virus in a person increased after finishing a course of treatment with Paxlovid. NIAID said the reports are being evaluated by the FDA and that agency will share additional recommendations on this topic, if appropriate.
A spokesperson for Pfizer said the company believes the viral rebound is unlikely to be related to treatment with Paxlovid, and we remain very confident in its clinical effectiveness at preventing severe outcomes from COVID-19 in high-risk patients.
MOLNUPIRAVIR
Molnupiravir, manufactured by Merck, is the second antiviral pill authorized by the FDA for emergency use. It should be started as soon as possible after COVID-19 diagnosis and within five days of symptoms.
The drug is given as four capsules taken every 12 hours for five days, for a total of 40 capsules. It is not authorized for use for longer than five consecutive days.
An interim analysis in 2021 found that Molnupiravir reduced the risk of hospitalization and death by about 50%, according to Merck.
How does Molnupiravir work?
When Monulpiravir enters a persons bloodstream, it blocks the ability of the virus that causes COVID-19 to replicate, Albert Shaw, M.D., Ph.D., a Yale Medicine infectious diseases specialist, explained.
Who can take Molnupiravir?
The drug is authorized for adults 18 and older who are at high risk for progression to severe COVID-19, including hospitalization or death. Its use should also be limited to situations in which other COVID-19 treatments such as Paxlovid "are not accessible or clinically appropriate, according to the FDA.
The drug is not authorized for people under the age of 18, and it isnt recommended for pregnant people because it could cause fetal harm.
Does Molnupiravir have any side effects?
Health experts say possible side effects of the drug include diarrhea, nausea and dizziness. Some allergic reactions have also been reported.
MONOCLONAL ANTIBODIES
What is monoclonal antibody treatment?
In February 2022, the FDA authorized a monoclonal antibody treatment called bebtelovimab. The treatment, made by Eli Lilly, is given intravenously soon after a person develops symptoms.
This treatment should also be used when others approved or authorized by the FDA are not accessible or clinically appropriate.
The U.S. Department of Health and Human Services (HHS) said in February that two other monoclonal antibody treatments another made by Lily and one made by Regeneron are highly unlikely to work against omicron. Early data suggest that bebtelovimab works against the omicron variant and omicron subvariant BA.2, according to HHS.
Who can receive monoclonal antibodies?
Bebtelovimab can be used to treat adults and children over the age of 12 who are not in the hospital, have mild to moderate COVID-19 symptoms, and who are at risk for severe COVID-19 or hospitalization, like Paxlovid.
PREVENTATIVE MEDICATION
Is there a preventative medication for COVID-19?
Some people ages 12 and older might be eligible for a preventative medication for COVID-19 called Evusheld, which has received emergency use authorization from the FDA.
Those who might qualify include moderately or severely immunocompromised people who might not have an adequate immune response to the COVID-19 vaccination or have had a history of allergic reactions to vaccines.
According to the CDC, the preventative medication contains two different antibodies that can help prevent COVID-19 and must be given before youre exposed to COVID-19.
What should you do if youre not at high risk of severe disease and test positive?
If you have COVID-19 and your doctor has told you to recover at home, you should get plenty of rest, stay well-hydrated, and take acetaminophen, ibuprofen or naproxen to reduce aches and pains.
Despite concerns earlier in the pandemic, it is safe to take ibuprofen and naproxen when you have COVID-19 and the CDC recommends the medications. Additionally, the World Health Organization (WHO) says there is no evidence ibuprofen has any negative effects for people with the virus.
The VERIFY team works to separate fact from fiction so that you can understand what is true and false. Please consider subscribing to our daily newsletter, text alerts and our YouTube channel. You can also follow us on Snapchat, Twitter, Instagram, Facebook and TikTok. Learn More
Text: 202-410-8808
View original post here:
VERIFY Fact Sheet: COVID-19 treatments - VERIFYThis.com
- Preventive or Preventative: Is There a Difference? - Merriam-Webster - January 21st, 2023
- Nurses: The Frontlines of Preventative Care - Bradley University Online - November 24th, 2022
- Functional Medicine of Idaho | Preventative Root Cause Medicine - October 29th, 2022
- This Indigenous Scientist Helped Save Lives as Covid Devastated the Navajo Nation - Scientific American - October 13th, 2022
- As governor calls for better mental health services, Healthy Wyoming says Medicaid expansion needed - Oil City News - October 13th, 2022
- Clinisys formed to help companies manage 'revolution' of lab science - OutSourcing-Pharma.com - October 13th, 2022
- Ainos Announces Positive Results from Additional Preclinical Study of Its Low-dose Oral Interferon Formulation Against New Variant Virus - Omicron -... - October 4th, 2022
- North Korea tells officials that 350,000 people died of diseases this year - Radio Free Asia - October 4th, 2022
- Episode 45 - Preventative Medicine: the Mediterranean Diet and the ... - September 25th, 2022
- Women's health got worse in 2021, global survey finds - WXOW.com - September 25th, 2022
- Wolf Creek PCN expands programming geared to health improvement - Lacombe Express - September 25th, 2022
- 1 in 10 Adults and 1 in 5 Teens Have Symptoms of Depression, What We Know - Healthline - September 25th, 2022
- Three tips to keep youth athletes in top nutritional shape this school year - The Philadelphia Inquirer - September 25th, 2022
- A blood test that detects cancer without symptoms could be a game changer for Louisiana - NOLA.com - September 25th, 2022
- Eric Idle on Surviving Pancreatic Cancer - TIME - September 25th, 2022
- Attacks on hospitals and healthcare in Ukraine: Joint Submission to the United Nations Independent International Commission of Inquiry on Ukraine,... - September 25th, 2022
- Spending on Food and lifestyle for preventive wellness is better than spending on medicines and treatment - The Financial Express - September 25th, 2022
- Exercise is Preventative Medicine - myBurbank.com - September 16th, 2022
- Best preventative medicine, health screening and anti-ageing clinics for HNWs in 2022 - Spear's WMS - September 16th, 2022
- The high hospital bills we make victims of rape and sexual violence pay - Vox.com - September 16th, 2022
- Press Release: CHMP recommends approval of Beyfortus (nirsevimab) for prevention of RSV disease in infants - StreetInsider.com - September 16th, 2022
- Why Now is the Time to Double Down on Virtual Care - HIT Consultant - September 16th, 2022
- Pickleball injuries are on the rise: 5 preventive tips to keep you on the court - The Manual - September 16th, 2022
- Opinion: From the Great War to the pandemic, doctors and nurses have always carried a heavy burden - The Globe and Mail - September 16th, 2022
- Can Sustainable Initiatives Benefit Your Team's Mental Health As Well As The Environment? - MinuteHack - September 16th, 2022
- Management of Chronic Migraine in Children and Adolescents | PHMT - Dove Medical Press - September 16th, 2022
- Workshop on promotion of physical activity in pregnancy | JMDH - Dove Medical Press - September 16th, 2022
- Men at The Emeline: how preventative medical care can help keep you on track - Australian Jewish News - August 30th, 2022
- Study: PCPs Need 26.7 Hours Per Day to Provide Recommended Care - Healthcare Innovation - August 30th, 2022
- New Guidelines Target Preventing Obesity In Midlife Women, But The Conclusion Is Somewhat Controversial - Suggest - August 30th, 2022
- Colleges need to prepare for monkeypox to spread among students, infectious disease experts say - PhillyVoice.com - August 30th, 2022
- BHERC Presents Its First Health Matters Film Screening and Panel Focused on Mental Health During The 28th Annual African American Film Marketplace and... - August 30th, 2022
- The Antitumor Effects of Quercetin - The Epoch Times - August 30th, 2022
- Why 4mg of folic acid will dramatically reduce the risk of birth defects during pregnancy - iNews - August 22nd, 2022
- Cure Is An Absolute, But Prevention Is The Ideal Vasanthi Ramachandran - CodeBlue - August 22nd, 2022
- GET PREPPED FOR A HEALTHY AND PRODUCTIVE SCHOOL YEAR - PR Newswire - August 22nd, 2022
- Researchers examine link between pesticides and thyroid cancer risk in Central California area - EurekAlert - August 22nd, 2022
- 5 Ways Your Body Is Telling You That You Need More Potassium, According to a Cardiologist and a Dietitian - Well+Good - August 22nd, 2022
- Restore Hyper Wellness Announces First Half of 2022 Performance Results with Over $60M in System-Wide Sales & Official Announcement of its Medical... - August 22nd, 2022
- Quest Diagnostics Aims to Close Gaps in Maternal Healthcare with New Obstetrics Test Panel that Includes Hepatitis C Screening - PR Newswire - August 22nd, 2022
- Flu Viral: Here Are The Most Common Queries Answered - NDTV - August 22nd, 2022
- Letters to the Editor, Aug. 19, 2022 - Toronto Sun - August 22nd, 2022
- Gambia: How Covid-19 vaccine contributes to the immunization of the most vulnerable - - Voice Gambia Newspaper - August 22nd, 2022
- The Effect of Maintenance Treatment with Erdosteine on Exacerbation Tr | COPD - Dove Medical Press - August 22nd, 2022
- Diagnostic Robotics has AI catching health problems before they take you to the ER - TechCrunch - August 14th, 2022
- Roches Xofluza issued FDA approval to treat influenza in children aged five years and older - PMLiVE - August 14th, 2022
- Ananta Medicare Provides Preventative Health Solutions to the World - PR Newswire - July 19th, 2022
- 5 "Health Tips" That are Terrible for Over 50s Eat This Not That - Eat This, Not That - July 19th, 2022
- 'Death Cap' Mushrooms Pose Threat to Dogs - University of Wisconsin School of Veterinary Medicine - University of Wisconsin School of Veterinary... - July 19th, 2022
- What Medicaid expansion means for new moms in Virginia - CBS 6 News Richmond WTVR - July 11th, 2022
- Healthcare for the Busy Bee - Flathead Beacon - July 11th, 2022
- The COVID BA.4 and BA.5 subvariants are highly transmissible. Here's what else people in CT need to know. - CT Insider - July 11th, 2022
- NHS to test using drones to fly chemotherapy drugs to Isle of Wight - The Guardian - July 11th, 2022
- The Role of Smoking and Body Mass Index in Mortality Risk Assessment for Geriatric Hip Fracture Patients - Cureus - July 11th, 2022
- Family Health Care Atlanta | Primary & Preventative Medicine - July 3rd, 2022
- Preventative medicine in Rochester Hills MI - July 3rd, 2022
- Joan Merriam: Prevention is the best medicine - The Union - June 22nd, 2022
- RIVERVIEW PRIMARY CARE PROVIDERS AVAILABLE TO OVERSEE YOUR HEALTH NEEDS - kroxam.com - June 22nd, 2022
- Prevention is the best medicine | Caseys Corner - Oroville Mercury-Register - June 22nd, 2022
- With Father's Day in mind, Mayo Clinic doctors remind men to be mindful of their health - WQOW TV News 18 - June 22nd, 2022
- Vilcek-Gold Award for Humanism in Healthcare will be presented this fall to Health Equity Leader Dr. Mona Fouad - City-sentinel - June 13th, 2022
- Margolius named Cleveland director of public health - Cleveland Jewish News - June 13th, 2022
- Three things to know about COVID-19 at this time: Dr. Robert A. Salata - cleveland.com - June 13th, 2022
- Remission seen in every rectal cancer patient in small study of drug - The Hill - June 13th, 2022
- University of Vermont: Advancing healthcare through impactful medicine - Study International News - June 13th, 2022
- On Three Different Continents, Rural Health Strains under the Weight of the Coronavirus - Scientific American - June 13th, 2022
- Do You Suffer from Knee Pain Due to Inflammation or Arthritis? Taking More Walks Will Help, a New Study Shows - Yahoo Life - June 13th, 2022
- Benign Breast Lumps | Health, Medicine and Fitness | siouxcityjournal.com - Sioux City Journal - June 13th, 2022
- 'We are definitely missing cases:' Just a fraction of COVID-19 cases reported in Washington - KING5.com - June 13th, 2022
- Flea-borne typhus outbreak puts three Aucklanders in hospital - Stuff - June 13th, 2022
- Promoters of Preventive Health A Key Role in Nursing - wknd. - May 15th, 2022
- What we know (and don't know) about North Korea's Covid outbreak - WREX.com - May 15th, 2022
- Metabolic Health and Skin Care: What to Know - WWD - May 15th, 2022
- Twitter: AI applications in healthcare and more - Pharmaceutical Technology - May 15th, 2022
- How Jefferson Health is harnessing philanthropy to address health disparities - Becker's Hospital Review - May 15th, 2022
- Digital Health Companies Bring Paradigm Change Across the Health... - Healthcare Tech Outlook - May 15th, 2022
- We all have a heros journey and our job is to triumph over our tragedies - Kitimat Northern Sentinel - May 15th, 2022
- Doctor Reveals How Woke Activists Have Infiltrated Medicine - Daily Signal - May 15th, 2022
- Study: Serious COVID-19 Outcomes Are More Likely Among Unvaccinated With Heart Issues - Pharmacy Times - May 15th, 2022
- What are the Key Opportunities on Offer for Self-care Medical Device Manufactures Exclusive Study - PharmiWeb.com - May 15th, 2022